Biochem Biophys Res Commun

1. WU W, Zeng C, Wu C, Wu T, et al
   Antidepressant effect of carvedilol on streptozotocin-induced diabetic peripheral neuropathy mice by altering gut microbiota.
   Biochem Biophys Res Commun. 2024;730:150374.
   

   >> Share

   
   

   
   BMJ

2. SETHI J
   Use of language in diabetes: what's in a name?
   BMJ. 2024;386:q1446.
   

   >> Share

   
   

   
   Diabet Med

3. PHILLIPS PCA, de Sousa Loreto Aresta Branco M, Cliff CL, Ward JK, et al
   Targeting senescence to prevent diabetic kidney disease: Exploring molecular mechanisms and potential therapeutic targets for disease management.
   Diabet Med. 2024 Jul 12:e15408. doi: 10.1111/dme.15408.
   

   >> Share

   
   
4. CHOWDHURY TA, Mukuba D, Casabar M, Byrne C, et al
   Management of diabetes in people with advanced chronic kidney disease.
   Diabet Med. 2024 Jul 11:e15402. doi: 10.1111/dme.15402.
   

   >> Share

   
   
5. MAGNY-NORMILUS C, Luppino F, Lyons K, Luu J, et al
   Food insecurity and diabetes management among adults of African descent: A systematic review.
   Diabet Med. 2024 Jul 11:e15398. doi: 10.1111/dme.15398.
   

   >> Share

   
   
6. STATHI D, Dhatariya KK, Mustafa OG
   Management of diabetes-related hyperglycaemic emergencies in advanced chronic kidney disease: Review of the literature and recommendations.
   Diabet Med. 2024 Jul 11:e15405. doi: 10.1111/dme.15405.
   

   >> Share

   
   
7. AL-CHALABI S, Sinha S, Kalra PA
   Enhancing clinical service design for multimorbidity management: A comprehensive approach to joined-up care for diabetes, chronic kidney disease, and heart failure.
   Diabet Med. 2024 Jul 8:e15403. doi: 10.1111/dme.15403.
   

   >> Share

   
   

   
   Diabetes

8. GRACE SL, Gillespie KM, Williams CL, Lampasona V, et al
   Autoantibodies to truncated GAD(96-585) antigen stratify risk of early insulin requirement in adult-onset diabetes.
   Diabetes. 2024 Jul 8:db230980. doi: 10.2337/db23-0980.
   

   >> Share

   
   
9. DELLA PEPA G, Patricio BG, Carli F, Sabatini S, et al
   GLP-1 receptor agonist treatment improved fasting and postprandial lipidomic profile independently of diabetes and weight loss.
   Diabetes. 2024 Jul 8:db230972. doi: 10.2337/db23-0972.
   

   >> Share

   
   
10. SUNILKUMAR S, Dennis MD
    REDD1 is a Promising Therapeutic Target to Combat the Development of Diabetic Complications: A Report on Research Supported by Pathway to Stop Diabetes.
    Diabetes. 2024 Jul 8:dbi240013. doi: 10.2337/dbi24-0013.
    

    >> Share

    
    

    
    Diabetes Care

11. BYNDLOSS M, Devkota S, Duca F, Hendrik Niess J, et al
    The Gut Microbiota and Diabetes: Research, Translation, and Clinical Applications-2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum.
    Diabetes Care. 2024 Jun 24:dci240052. doi: 10.2337/dci24-0052.
    

    >> Share

    
    
12. JOHANSSON KS, Espen JS, Petersen TS, Christensen MB, et al
    Rational Pharmacotherapy in Type 2 Diabetes: Danish Data From 2002 to 2020 on Mortality, Diabetes- Related Outcomes, Adverse Events, and Medication Expenses.
    Diabetes Care. 2024 Jul 12:dc240619. doi: 10.2337/dc24-0619.
    

    >> Share

    
    
13. BISMUTH E, Tubiana-Rufi N, Rynders CA, Dalla-Vale F, et al
    Sustained 3-Year Improvement of Glucose Control With Hybrid Closed Loop in Children With Type 1 Diabetes While Going Through Puberty.
    Diabetes Care. 2024 Jul 10:dc240916. doi: 10.2337/dc24-0916.
    

    >> Share

    
    

    
    Diabetes Obes Metab

14. CHEUNG JTK, Yang A, Wu H, Lau ESH, et al
    Association of dipeptidyl peptidase-4 inhibitor initiation at glycated haemoglobin <7.5% with reduced major clinical events mediated by low glycated haemoglobin variability.
    Diabetes Obes Metab. 2024;26:3339-3351.
    

    >> Share

    
    
15. TANGRI N, Ferguson TW, Bamforth RJ, Leon SJ, et al
    Machine learning for prediction of chronic kidney disease progression: Validation of the Klinrisk model in the CANVAS Program and CREDENCE trial.
    Diabetes Obes Metab. 2024;26:3371-3380.
    

    >> Share

    
    
16. XIE P, Abildlund MT, Baekdal TA, He X, et al
    A phase 1, randomized, double-blind, placebo-controlled trial investigating the pharmacokinetics, pharmacodynamics, safety and tolerability of oral semaglutide in healthy Chinese subjects.
    Diabetes Obes Metab. 2024;26:3068-3077.
    

    >> Share

    
    
17. BERGENSTAL RM, Philis-Tsimikas A, Wysham C, Carr MC, et al
    Once-weekly insulin efsitora alfa: Design and rationale for the QWINT phase 3 clinical development programme.
    Diabetes Obes Metab. 2024;26:3020-3030.
    

    >> Share

    
    
18. CHAN JCN, Yang A, Chu N, Chow E, et al
    Current type 2 diabetes guidelines: Individualized treatment and how to make the most of metformin.
    Diabetes Obes Metab. 2024 Jul 11. doi: 10.1111/dom.15700.
    

    >> Share

    
    
19. RIESTER MR, Zullo AR, Joshi R, Daiello LA, et al
    Comparative safety and cardiovascular effectiveness of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in nursing homes.
    Diabetes Obes Metab. 2024;26:3403-3417.
    

    >> Share

    
    
20. MOHAMMEDI K, Hess S, McQueen M, Pigeyre M, et al
    Determinants of serious health outcome-free status in middle-aged and older people with dysglycaemia: Exploratory analysis of the ORIGIN trial.
    Diabetes Obes Metab. 2024;26:3272-3280.
    

    >> Share

    
    
21. HAKARIYA H, Ohnishi M, Tanimoto T
    Japan initiates market authorization of weight-loss drug semaglutide under universal health coverage, but with stringent prescription restrictions.
    Diabetes Obes Metab. 2024;26:3006-3008.
    

    >> Share

    
    
22. KLONOFF DC, Kim SH, Galindo RJ, Joseph JI, et al
    Risks of peri- and postoperative complications with glucagon-like peptide-1 receptor agonists.
    Diabetes Obes Metab. 2024;26:3128-3136.
    

    >> Share

    
    
23. CEFALO CMA, Riccio A, Succurro E, Marini MA, et al
    Frequency of prediabetes in individuals with increased adiposity and metabolically healthy or unhealthy phenotypes.
    Diabetes Obes Metab. 2024;26:3191-3199.
    

    >> Share

    
    
24. JONES KL, Marathe CS, Wu T, Rayner CK, et al
    Getting the measure of the pressure: Optimal assessment of the effects of glucagon-like peptide-1 receptor agonists on blood pressure.
    Diabetes Obes Metab. 2024;26:3003-3005.
    

    >> Share

    
    
25. LI W, Qin R, Tang Z, Wang C, et al
    Inhibition of inflammation and apoptosis through the cyclic GMP-AMP synthase-stimulator of interferon genes pathway by stress granules after ALKBH5 demethylase activation during diabetic myocardial ischaemia-reperfusion injury.
    Diabetes Obes Metab. 2024 Jul 11. doi: 10.1111/dom.15743.
    

    >> Share

    
    
26. WEIR MR
    Cardiovascular risk reduction in type 2 diabetes: What the non-specialist needs to know about current guidelines.
    Diabetes Obes Metab. 2024 Jul 10. doi: 10.1111/dom.15764.
    

    >> Share

    
    
27. KAZIBWE R, Singleton M, Bancks MP, Namutebi J, et al
    Efficacy of Aspirin for primary prevention among adults with high-risk type 2 diabetes in the ACCORD trial.
    Diabetes Obes Metab. 2024 Jul 10. doi: 10.1111/dom.15753.
    

    >> Share

    
    
28. AL-OZAIRI E, Irshad M, AlKandari J, Mashankar A, et al
    Liver fibrosis and liver stiffness in patients with obesity and type 1 diabetes.
    Diabetes Obes Metab. 2024 Jul 10. doi: 10.1111/dom.15760.
    

    >> Share

    
    
29. ABBASI M, Heath B, McGinness L
    Advances in metformin-delivery systems for diabetes and obesity management.
    Diabetes Obes Metab. 2024 Jul 10. doi: 10.1111/dom.15759.
    

    >> Share

    
    
30. DE KLERK JA, Beulens JWJ, Bijkerk R, van Zonneveld AJ, et al
    Circulating small non-coding RNAs are associated with the insulin-resistant and obesity-related type 2 diabetes clusters.
    Diabetes Obes Metab. 2024 Jul 10. doi: 10.1111/dom.15786.
    

    >> Share

    
    
31. AUZANNEAU M, Seufert J, Zimny S, Haak T, et al
    Regional socioeconomic deprivation associated with the use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes in Germany.
    Diabetes Obes Metab. 2024 Jul 9. doi: 10.1111/dom.15741.
    

    >> Share

    
    
32. BRIEDITIS E, Li X, Sundquist K, Jansaker F, et al
    Vulvovaginal candidiasis and type 2 diabetes: A nationwide retrospective cohort study.
    Diabetes Obes Metab. 2024 Jul 8. doi: 10.1111/dom.15757.
    

    >> Share

    
    
33. HOU T, Li Y, Yan Q, Zhou Y, et al
    The interaction effect between BMI, diabetes and age at diabetes onset on the risk of thyroid cancer: A population-based cohort study in Shanghai, China.
    Diabetes Obes Metab. 2024 Jul 8. doi: 10.1111/dom.15746.
    

    >> Share

    
    
34. 
    Correction to "Cardiovascular health metrics defined by Life's Essential 8 scores and subsequent macrovascular and microvascular complications in individuals with type 2 diabetes: A prospective cohort study".
    Diabetes Obes Metab. 2024 Jul 8. doi: 10.1111/dom.15806.
    

    >> Share

    
    
35. HAN KA, Hwang YC, Moon SJ, Cho HC, et al
    Dual add-on therapy of gemigliptin and dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin alone: The SOLUTION 2 study.
    Diabetes Obes Metab. 2024 Jul 8. doi: 10.1111/dom.15717.
    

    >> Share

    
    
36. DAVIDSON MB, Davidson SJ
    Real-world evidence for computerized insulin dose-adjustment algorithms in the effective use of continuous glucose monitoring by primary care clinicians.
    Diabetes Obes Metab. 2024;26:3475-3477.
    

    >> Share

    
    
37. DIMAKOS J, Cui Y, Platt RW, Renoux C, et al
    Fluoroquinolones and the risk of severe hypoglycaemia among sulphonylurea users: Population-based cohort study.
    Diabetes Obes Metab. 2024;26:3088-3098.
    

    >> Share

    
    
38. ASLAM A, Chapman A, Urwin A, Ohol S, et al
    Real-world data from first UK Omnipod 5 users: A single-centre observational study.
    Diabetes Obes Metab. 2024;26:3462-3465.
    

    >> Share

    
    

    
    Diabetologia

39. SCULLY KJ, Marks BE, Putman MS
    Advances in diabetes technology to improve the lives of people with cystic fibrosis.
    Diabetologia. 2024 Jul 12. doi: 10.1007/s00125-024-06223.
    

    >> Share

    
    
40. SCHOELWER MJ, DeBoer MD, Breton MD
    Use of diabetes technology in children.
    Diabetologia. 2024 Jul 12. doi: 10.1007/s00125-024-06218.
    

    >> Share

    
    
41. WANG W, Bain SC, Bian F, Chen R, et al
    Efficacy and safety of oral semaglutide monotherapy vs placebo in a predominantly Chinese population with type 2 diabetes (PIONEER 11): a double-blind, Phase IIIa, randomised trial.
    Diabetologia. 2024 Jul 10. doi: 10.1007/s00125-024-06142.
    

    >> Share

    
    
42. JI L, Agesen RM, Bain SC, Fu F, et al
    Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial.
    Diabetologia. 2024 Jul 10. doi: 10.1007/s00125-024-06133.
    

    >> Share

    
    
43. LUNA-MARCO C, Devos D, Cacace J, Fernandez-Reyes M, et al
    Molecular circadian clock disruption in the leukocytes of individuals with type 2 diabetes and overweight, and its relationship with leukocyte-endothelial interactions.
    Diabetologia. 2024 Jul 10. doi: 10.1007/s00125-024-06219.
    

    >> Share

    
    

    
    Eur J Endocrinol

44. FOUNTAS A, Coulden A, Fernandez-Garcia S, Tsermoulas G, et al
    Central diabetes insipidus (vasopressin deficiency) after surgery for pituitary tumours: A systematic review and meta-analysis.
    Eur J Endocrinol. 2024 Jul 12:lvae084. doi: 10.1093.
    

    >> Share

    
    

    
    J Am Coll Cardiol

45. BABER U
    Stent Failure After Percutaneous Coronary Intervention in Diabetes Mellitus: Does Glycemic Control Matter?
    J Am Coll Cardiol. 2024;84:273-275.
    

    >> Share

    
    
46. GUGLIN M, Hillerson D
    Exploring Racial and Ethnic Differences in Diabetic Cardiomyopathy: The Physical Burden of Health Disparities.
    J Am Coll Cardiol. 2024;84:244-246.
    

    >> Share

    
    
47. LOPEZ J, Liu Y, Butler J, Del Prato S, et al
    Racial Differences in Diabetic Cardiomyopathy: The ARISE-HF Trial.
    J Am Coll Cardiol. 2024;84:233-243.
    

    >> Share

    
    

    
    J Clin Endocrinol Metab

48. JONSDOTTIR B, Clasen JL, Vehik K, Lernmark A, et al
    Early appearance of thyroid autoimmunity in children followed from birth for type 1 diabetes risk.
    J Clin Endocrinol Metab. 2024 Jul 12:dgae478. doi: 10.1210.
    

    >> Share

    
    
49. TIAN S, Guo T, Qian F, Qiu Z, et al
    Fish Oil, Plasma n-3 PUFAs, and Risk of Macro- and Microvascular Complications among Individuals with Type 2 Diabetes.
    J Clin Endocrinol Metab. 2024 Jul 12:dgae482. doi: 10.1210.
    

    >> Share

    
    
50. FARAJ M, Schwartz AV, Burghardt AJ, Black D, et al
    Risk Factors for Bone Microarchitecture Impairments in Older Men with Type 2 Diabetes - The MrOS Study.
    J Clin Endocrinol Metab. 2024 Jul 12:dgae452. doi: 10.1210.
    

    >> Share

    
    
51. WANG HH, Lin SH, Hung SY, Chiou YY, et al
    Renal protective effect of metformin in type 2 diabetes patients.
    J Clin Endocrinol Metab. 2024 Jul 11:dgae477. doi: 10.1210.
    

    >> Share

    
    
52. HENNEY AE, Gillespie CS, Lai JYM, Schofield P, et al
    Risk of type 2 diabetes, MASLD and cardiovascular disease in people living with polycystic ovary syndrome.
    J Clin Endocrinol Metab. 2024 Jul 11:dgae481. doi: 10.1210.
    

    >> Share

    
    
53. SHAH VP, Nayfeh T, Alsawaf Y, Saadi S, et al
    A Systematic Review Supporting the Endocrine Society Clinical Practice Guidelines on Vitamin D.
    J Clin Endocrinol Metab. 2024;109:1961-1974.
    

    >> Share

    
    
54. GROSSMANN M, Robledo KP, Daniel M, Handelsman DJ, et al
    Testosterone Treatment, Weight Loss, and Health-related Quality of Life and Psychosocial Function in Men: A 2-year Randomized Controlled Trial.
    J Clin Endocrinol Metab. 2024;109:2019-2028.
    

    >> Share

    
    
55. SIMS EK, Cuthbertson D, Jacobsen L, Ismail HM, et al
    Comparisons of Metabolic Measures to Predict T1D vs Detect a Preventive Treatment Effect in High-Risk Individuals.
    J Clin Endocrinol Metab. 2024;109:2116-2123.
    

    >> Share

    
    
56. CORDINER RLM, Bedair K, Mari A, Pearson E, et al
    Low-Dose Sulfonylurea Plus DPP4 Inhibitor Lower Blood Glucose and Enhance Beta-Cell Function Without Hypoglycemia.
    J Clin Endocrinol Metab. 2024;109:2106-2115.
    

    >> Share

    
    

    
    J Diabetes Complications

57. GOTTLIEB D, Abushamat LA, Nadeau KJ, Regensteiner JG, et al
    Muscle mitochondrial function is impaired in adults with type 1 diabetes.
    J Diabetes Complications. 2024;38:108798.
    

    >> Share

    
    
58. LUO Y, Qin Y, Kong L, Long J, et al
    Clinical and pathological characteristics of gestational diabetes mellitus with different insulin resistance.
    J Diabetes Complications. 2024;38:108796.
    

    >> Share

    
    
59. DE PAULA AVL, Dykstra GM, da Rocha RB, Magalhaes AT, et al
    The association of diabetic peripheral neuropathy with cardiac autonomic neuropathy in individuals with diabetes mellitus: A systematic review.
    J Diabetes Complications. 2024;38:108802.
    

    >> Share

    
    

    
    J Nutr

60. SALO TEI, Hakola L, Niinisto S, Takkinen HM, et al
    Gut inflammation markers, diet, and risk of islet autoimmunity in Finnish children - a nested case-control study.
    J Nutr. 2024 May 23:S0022-3166(24)00292-X. doi: 10.1016/j.tjnut.2024.
    

    >> Share

    
    

    
    J Pediatr

61. GERHOLD K, Al-Azazi S, El-Matary W, Katz LY, et al
    Healthcare Utilization and Direct Costs Prior to Subspecialty Care in Children with Chronic Pain Compared with Other Chronic Childhood Diseases: A Cohort Study.
    J Pediatr. 2024 Apr 4:114046. doi: 10.1016/j.jpeds.2024.114046.
    

    >> Share

    
    

    
    JAMA

62. LEVI M
    Preoperative GLP-1 Receptor Agonists and Risk of Postoperative Respiratory Complications.
    JAMA. 2024;332:171.
    

    >> Share

    
    
63. HOBAI IA
    Preoperative GLP-1 Receptor Agonists and Risk of Postoperative Respiratory Complications.
    JAMA. 2024;332:171-172.
    

    >> Share

    
    
64. MILDER DA, Milder TY, Kam P
    Preoperative GLP-1 Receptor Agonists and Risk of Postoperative Respiratory Complications.
    JAMA. 2024;332:170-171.
    

    >> Share

    
    
65. HARRIS E
    Guidelines May Fall Short as More Older Adults Live With Type 1 Diabetes.
    JAMA. 2024 Jul 12. doi: 10.1001/jama.2024.12235.
    

    >> Share

    
    
66. HARRIS E
    Fasting, Meal Substitute Improved Blood Sugar More Than Diabetes Drugs.
    JAMA. 2024 Jul 12. doi: 10.1001/jama.2024.12233.
    

    >> Share

    
    

    
    Metabolism

67. CAI Z, Yang Y, Zhong J, Ji Y, et al
    cGAS suppresses beta-cell proliferation by a STING-independent but CEBPbeta-dependent mechanism.
    Metabolism. 2024;157:155933.
    

    >> Share

    
    
68. HUTTASCH M, Roden M, Kahl S
    Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?
    Metabolism. 2024 May 21:155937. doi: 10.1016/j.metabol.2024.155937.
    

    >> Share

    
    
69. ROSELL-DIAZ M, Petit-Gay A, Molas-Prat C, Gallardo-Nuell L, et al
    Metformin-induced changes in the gut microbiome and plasma metabolome are associated with cognition in men.
    Metabolism. 2024;157:155941.
    

    >> Share

    
    

    
    N Engl J Med

70. HERRINGTON WG, Haynes R
    Diabetic Kidney Disease - Semaglutide Flows into the Mainstream.
    N Engl J Med. 2024;391:178-179.
    

    >> Share

    
    

    
    Nutr Metab (Lond)

71. WANG D, Ye H, Liu S, Duan H, et al
    Sex- and age-specific associations of serum essential elements with diabetes among the Chinese adults: a community-based cross-sectional study.
    Nutr Metab (Lond). 2024;21:44.
    

    >> Share

    
    
72. GUAN J, Liu T, Yang K, Chen H, et al
    Dried fruit intake and lower risk of type 2 diabetes: a two-sample mendelian randomization study.
    Nutr Metab (Lond). 2024;21:46.
    

    >> Share

    
    

    
    Obstet Gynecol

73. WEN T, Friedman AM, Gyamfi-Bannerman C, Powe CE, et al
    Diabetic Ketoacidosis and Adverse Outcomes Among Pregnant Individuals With Pregestational Diabetes in the United States, 2010-2020.
    Obstet Gynecol. 2024 Jul 11. doi: 10.1097/AOG.0000000000005667.
    

    >> Share

    
    

    
    Ophthalmology

74. YANG S, Liu R, Xin Z, Zhu Z, et al
    Plasma metabolomics identifies key metabolites and improves prediction of diabetic retinopathy: development and validation across multi-national cohorts.
    Ophthalmology. 2024 Jul 5:S0161-6420(24)00415.
    

    >> Share

    
    

    
    PLoS Med

75. DE BRUN M, Magnuson A, Montgomery S, Patil S, et al
    Changing diagnostic criteria for gestational diabetes (CDC4G) in Sweden: A stepped wedge cluster randomised trial.
    PLoS Med. 2024;21:e1004420.
    

    >> Share

    
    
76. QIAN X, Wang J, Gong Q, An Y, et al
    Non-diabetes status after diagnosis of impaired glucose tolerance and risk of long-term death and vascular complications: A post hoc analysis of the Da Qing Diabetes Prevention Outcome Study.
    PLoS Med. 2024;21:e1004419.
    

    >> Share

    
    

    
    PLoS One

77. MOON SY, Kim HJ, Kim JK, Kim J, et al
    An examination of the mechanisms driving the therapeutic effects of an AAV expressing a soluble variant of VEGF receptor-1.
    PLoS One. 2024;19:e0305466.
    

    >> Share

    
    
78. SIVAKUMAR A, Rana S, Rofaiel D, Ahmad T, et al
    "The straw that broke the camel's back": An analysis of racialized women clinicians' experiences providing diabetes care.
    PLoS One. 2024;19:e0305473.
    

    >> Share

    
    
79. LI Z, Jia B, Guo Z, Zhang K, et al
    Therapeutic potential of salidroside in type I diabetic erectile dysfunction: Attenuation of oxidative stress and apoptosis via the Nrf2/HO-1 pathway.
    PLoS One. 2024;19:e0306926.
    

    >> Share

    
    
80. BORIE YA, Tamiso A, Gutema K, Jisso M, et al
    Psychological distress and its associated factors among people with specific chronic conditions (diabetes and/or hypertension) in the Sidama region of southern Ethiopia: A cross-sectional study.
    PLoS One. 2024;19:e0303196.
    

    >> Share

    
    
81. LIN YW, Chen PC, Lin CH, Lin MH, et al
    Investigating medication adherence among Taiwanese patient with hypertension, hyperlipidemia, and diabetes: A pilot study using the Chinese version of a Two-Part Medication Nonadherence Scale and the NHI MediCloud system.
    PLoS One. 2024;19:e0304442.
    

    >> Share

    
    
82. MITTAL R, Keith G, Lacey M, Lemos JRN, et al
    Diabetes mellitus, hearing loss, and therapeutic interventions: A systematic review of insights from preclinical animal models.
    PLoS One. 2024;19:e0305617.
    

    >> Share

    
    
83. TANG HX, Li JJ, Yuan Y, Ling Y, et al
    Comparing the efficacy of dexamethasone implant and anti-VEGF for the treatment of macular edema: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0305573.
    

    >> Share

    
    
84. NAGLER L, Eissmann C, Wasenitz M, Bahlmann F, et al
    The association between maternal obesity and fetomaternal outcomes in twin pregnancies.
    PLoS One. 2024;19:e0306877.
    

    >> Share

    
    
85. OLANI KUTA A, Dida N
    Covid-19 vaccine hesitancy and its predictors among diabetic patients on follow-up at public hospitals in Nekemte Town, Western Ethiopia.
    PLoS One. 2024;19:e0305200.
    

    >> Share

    
    
86. SSEGUYA W, Bahendeka S, MacLennan S, Mody N, et al
    Diabetes mellitus in sub-saharan Africa during the COVID-19 pandemic: A scoping review.
    PLoS One. 2024;19:e0305112.
    

    >> Share

    
    
87. BONILLA-ESCOBAR FJ, Ghobrial AI, Gallagher DS, Eller A, et al
    Comprehensive insights into a decade-long journey: The evolution, impact, and human factors of an asynchronous telemedicine program for diabetic retinopathy screening in Pennsylvania, United States.
    PLoS One. 2024;19:e0305586.
    

    >> Share

    
    
88. MANSOR E, Ahmad N, Mohd Zulkefli NA, Lim PY, et al
    Incidence and determinants of low birth weight in Peninsular Malaysia: A multicentre prospective cohort study.
    PLoS One. 2024;19:e0306387.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share